1.Truthmann J, Busch M, Scheidt-Nave C, Mensink GB, Gößwald A, Endres M, et al. Modifiable cardiovascular risk factors in adults aged 40–79 years in Germany with and without prior coronary heart disease or stroke. BMC public health. 2015;15(1):701. https://doi.org/10.1186/s12889–015–1929–5
2.Sardarinia M, Akbarpour S, Lotfaliany M, Bagherzadeh-Khiabani F, Bozorgmanesh M, Sheikholeslami F, et al. Risk factors for incidence of cardiovascular diseases and all-cause mortality in a middle eastern population over a decade follow-up: Tehran lipid and glucose study. PloS one. 2016;11(12):e0167623. https://doi.org/10.1371/journal.pone.0167623
3.Organization WH. Global action plan for the prevention and control of noncommunicable diseases 2013–2020. 2013.
4.Peykari N, Hashemi H, Dinarvand R, Haji-Aghajani M, Malekzadeh R, Sadrolsadat A, et al. National action plan for non-communicable diseases prevention and control in Iran; a response to emerging epidemic. Journal of Diabetes & Metabolic Disorders. 2017;16(1):3. https://doi.org/10.1186/s40200–017–0288–4
5.Sadeghi M, Haghdoost A, Bahrampour A, Dehghani M. Modeling the burden of cardiovascular diseases in Iran from 2005 to 2025: The impact of demographic changes. Iranian journal of public health. 2017;46(4):506.
6.Aghamohammadi S, Kazemi E, Khosravi A, Kazemeini H. The trend of ten leading causes of death in the Islamic Republic of Iran, 2006–2011. Iranian Journal of Epidemiology. 2017;12(4):1–11.
7.Evaluation IoHMa. Global burden of Diseases. Washington,. Available from: http://www.healthdata.org/iran.
8.Stewart J, Manmathan G, Wilkinson P. Primary prevention of cardiovascular disease: A review of contemporary guidance and literature. JRSM cardiovascular disease. 2017;6:2048004016687211. doi: 10.1177/2048004016687211.
9.Perel P, Avezum A, Huffman M, Pais P, Rodgers A, Vedanthan R, et al. Reducing premature cardiovascular morbidity and mortality in people with atherosclerotic vascular disease. Global heart. 2015;10(2):99–110 doi: 10.1016/j.gheart.2015.04.003
10.Leong D, Joseph P, McKee M, Anand S, Teo K, Schwalm J, et al. Reducing the global burden of cardiovascular disease, part 2: prevention and treatment of cardiovascular disease. Circulation research. 2017;121(6):695–710. doi: 10.1161/CIRCRESAHA.117.308903.
11.Jousilahti P, Laatikainen T, Peltonen M, Borodulin K, Männistö S, Jula A, et al. Primary prevention and risk factor reduction in coronary heart disease mortality among working aged men and women in eastern Finland over 40 years: population based observational study. bmj. 2016;352:i721.
12.Psaltopoulou T, Hatzis G, Papageorgiou N, Androulakis E, Briasoulis A, Tousoulis D. Socioeconomic status and risk factors for cardiovascular disease: impact of dietary mediators. Hellenic Journal of Cardiology. 2017;58(1):32–42. doi: 10.1016/j.hjc.2017.01.022.
13.Tousoulis D. Socioeconomic status and cardiac disease in Europe: A modern-day problem in the era of economic crisis. Hellenic journal of cardiology: HJC = Hellenike kardiologike epitheorese. 2017;58(1):1–3 doi: 10.1016/j.hjc.2017.03.014.
14.Najafipour H, Afshari M, Rostamzadeh F. Prevalence of multiple coronary artery disease risk factors in kerman: A population-based study in Southeast Iran. Iranian journal of medical sciences. 2018;43(2):140–149
15.Foster H, Celis-Morales C, Nicholl B, Petermann-Rocha F, Pell J, Gill J, et al. The effect of socioeconomic deprivation on the association between an extended measurement of unhealthy lifestyle factors and health outcomes: a prospective analysis of the UK Biobank cohort. The Lancet Public Health. 2018;3(12):e576-e85. doi: 10.1016/S2468–2667(18)30200–7.
16.Kishi T, Okada E, Sato A, Ishikawa M, Ukawa S, Nakamura K, et al. Regional differences in mortality and food and nutrient intake and their associations among secondary healthcare service areas in Hokkaido. [Nihon koshu eisei zasshi] Japanese journal of public health. 2018;65(5):210–22. DOI: 10.11236/jph.65.5_210
17.Walker J, Colhoun H, Livingstone S, McCrimmon R, Petrie J, Sattar N, et al. Type 2 diabetes, socioeconomic status and life expectancy in Scotland (2012–2014): a population-based observational study. Diabetologia. 2018;61(1):108–16. doi: 10.1007/s00125–017–4478-x.
18.Fujiyoshi N, Arima H, Satoh A, Ojima T, Nishi N, Okuda N, et al. Associations between socioeconomic status and the prevalence and treatment of hypercholesterolemia in a general Japanese population: NIPPON DATA2010. Journal of atherosclerosis and thrombosis. 2018;25(7):606–20.
19.Young D, Fischer H, Arterburn D, Bessesen D, Cromwell L, Daley M, et al. Associations of overweight/obesity and socioeconomic status with hypertension prevalence across racial and ethnic groups. The Journal of Clinical Hypertension. 2018;20(3):532–40. doi: 10.1111/jch.13217
20.Mirzaei M, Salehi-Abargouei A, Mirzaei M, Mohsenpour M. Cohort Profile: The Yazd Health Study (YaHS): a population-based study of adults aged 20–70 years (study design and baseline population data). International journal of epidemiology. 2017;47(3):697–8h. https://doi.org/10.1093/ije/dyx231
21.Chobanian A, Bakris G, Black H, Cushman W, Green L, Izzo Jr J, et al. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. Jama. 2003;289(19):2560–71. DOI:10.1001/jama.289.19.2560
22.Who EC. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet (London, England). 2004;363(9403):157–63. DOI:10.1016/S0140–6736(03)15268–3
23.Gil Á, Martinez de Victoria E, Olza J. Indicators for the evaluation of diet quality. Nutricion hospitalaria. 2015;31(3).128–44. doi: 10.3305/nh.2015.31.
24.Baghiani Moghaddam M, Bakhtari Aghdam F, Asghari Jafarabadi M, Allahverdipour H, Nikookheslat S, Safarpour S. The Iranian Version of International Physical Activity Questionnaire (IPAQ) in Iran: content and construct validity, factor structure, internal consistency and stability. World applied sciences journal. 2012;18(8):1073–80.
25.Committee IR. Guidelines for data processing and analysis of the International Physical Activity Questionnaire (IPAQ)-short and long forms. http://www ipaq ki se/scoring pdf. 2005.
26.Kriaucioniene V, Klumbiene J, Petkeviciene J, Sakyte E. Time trends in social differences in nutrition habits of a Lithuanian population: 1994–2010. BMC Public Health. 2012;12(1):218. https://doi.org/10.1186/1471–2458–12–218
27.Tabatabaei-Malazy O, Qorbani M, Samavat T, Sharifi F, Larijani B, Fakhrzadeh H. Prevalence of dyslipidemia in Iran: a systematic review and meta-analysis study. International journal of preventive medicine. 2014;5(4):373–393
28.Namayandeh S, Sadr S, Ansari Z, Rafiei M. A cross-sectional study of the prevalence of coronary artery disease traditional risk factors in Yazd urban population, Yazd healthy heart project.International Cardiovascular Research Journal 2011;5(1):7–13
29.Jafari-Adli S, Jouyandeh Z, Qorbani M, Soroush A, Larijani B, Hasani-Ranjbar S. Prevalence of obesity and overweight in adults and children in Iran; a systematic review. Journal of Diabetes & Metabolic Disorders. 2014;13(1):121. https://doi.org/10.1186/s40200–014–0121–2
30.Najafipour H, Yousefzadeh G, Forood A, Karamouzian M, Shadkam M, Mirzazadeh A. Overweight and obesity prevalence and its predictors in a general population: A community-based study in Kerman, Iran (Kerman coronary artery diseases risk factors studies). ARYA atherosclerosis. 2016;12(1):18–27
31.Kolahi A, Moghisi A, Ekhtiari Y. Socio-demographic determinants of obesity indexes in Iran: findings from a nationwide STEPS survey. Health promotion perspectives. 2018;8(3):187–194. doi: 10.15171/hpp.2018.25
32.Fakhrzadeh H, Djalalinia S, Mirarefin M, Arefirad T, Asayesh H, Safiri S, et al. Prevalence of physical inactivity in Iran: a systematic review. Journal of cardiovascular and thoracic research. 2016;8(3):9297. doi: 10.15171/jcvtr.2016.20
33.Najafipour H, Moazenzadeh M, Afshari M, Nasri H, Khaksari M, Forood A, et al. The prevalence of low physical activity in an urban population and its relationship with other cardiovascular risk factors: Findings of a community-based study (KERCADRS) in southeast of Iran. ARYA atherosclerosis. 2016;12(5):212–219.
34.Sahebkar M, Heidarian Miri H, Noormohammadpour P, Akrami R, Mansournia N, Tavana B, et al. Prevalence and correlates of low physical activity in the Iranian population: National survey on non‐communicable diseases in 2011. Scandinavian journal of medicine & science in sports. 2018;28(8):1916–24.https://doi.org/10.1111/sms.13082
35.Khavaninzadeh A, Sarbaz, M., & Ahmadian, Sh. Investigating the changing process of green spaces during the past three decades using remote evaluation (Case study: Yazd). Journal of Geography and Urban Space Development 2018;4(2):99–115.
36.Jafari M, Heidari Noshahr M, Parsa E. Role of Providing Urban Services in Creating Marginal neighborhoods of Yazd City Based on Citizenship Rights. Bioethics Journal. 2018;8:83–94. DOI: https://doi.org/10.22037/bj.v8i0.23226
37.Nemati S, Rafei A, Freedman N, Fotouhi A, Asgary F, Zendehdel K. Cigarette and water-pipe use in Iran: Geographical distribution and time trends among the adult population; A pooled analysis of national STEPS surveys, 2006–2009. Archives of Iranian medicine. 2017;20(5):295.
38.Moosazadeh M, Ziaaddini H, Mirzazadeh A, Ashrafi-Asgarabad A, Haghdoost A. Meta-analysis of smoking prevalence in Iran. Addiction & health. 2013;5(3–4):140.
39.Yang W, Lu J, Weng J, Jia W, Ji L, Xiao J, et al. Prevalence of diabetes among men and women in China. New England Journal of Medicine. 2010;362(12):1090–101. doi: 10.1056/NEJMoa0908292
40.Zhou M, Astell-Burt T, Bi Y, Feng X, Jiang Y, Li Y, et al. Geographical variation in diabetes prevalence and detection in China: multilevel spatial analysis of 98,058 adults. Diabetes care. 2015;38(1):72–81. https://doi.org/10.2337/dc14–1100
41.Maier W, Holle R, Hunger M, Peters A, Meisinger C, Greiser K, et al. The impact of regional deprivation and individual socio‐economic status on the prevalence of Type 2 diabetes in Germany. A pooled analysis of five population‐based studies. Diabetic Medicine. 2013;30(3):e78-e86. doi: 10.1111/dme.12062
42.Abebe S, Berhane Y, Worku A, Getachew A. Prevalence and associated factors of hypertension: a crossectional community based study in Northwest Ethiopia. PloS one. 2015;10(4):e0125210. https://doi.org/10.1371/journal.pone.0125210
43.Laohasiriwong W, Puttanapong N, Singsalasang A. Prevalence of hypertension in Thailand: Hotspot clustering detected by spatial analysis. Geospatial health. 2018;13(1). DOI https://doi.org/10.4081/gh.2018.608